Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of etomidate–midazolam and propofol–midazolam sedation for EGD and colonoscopy
KCT0004621Phase 4Not yet recruiting
- Sponsor
- Daewoong Pharmaceutical
- Start
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of etomidate, propofol and midazolam in None (2 arms), sponsored by Daewoong Pharmaceutical. Primary endpoint: Respiratory depression incidence. Planned start Feb 2020; status: not yet recruiting.
02
Drugs
etomidatepropofolmidazolam
Beyond the preview
Go deeper on KCT0004621.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0004621.